Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Youhei Hasebe"'
Autor:
Keiichi Koizumi, Takeshi Moriguchi, Kenichi Matsuda, Atsushi Watanabe, Masashi Yoshizawa, Yosuke Kono, Yuto Sunaga, Nobuyuki Katsumata, Youhei Hasebe, M Hosiai, Hiroaki Kise, Takako Toda, Kanji Sugita
Publikováno v:
European Heart Journal. 39
Autor:
Keiichi Koizumi, Y Okada, Shigefumi Yokota, Yosuke Arima, Hiroshi Onimaru, Isato Fukushi, Minako Hoshiai, K Kono, Masashi Yoshizawa, Kanji Sugita, Hiroaki Kise, Youhei Hasebe, Takako Toda
Publikováno v:
European Heart Journal. 39
P4780Activation of astrocytes is requred for the persistence of post-stress blood pressure elevation
Autor:
Yosuke Kono, Keiichi Koizumi, Y Kakinuma, Minako Hoshiai, M Pokorski, Youhei Hasebe, Shigefumi Yokota, Isato Fukushi, Y Okada, S Sugama, Kanji Sugita, J. Horiuchi, Kotaro Takeda
Publikováno v:
European Heart Journal. 39
Autor:
Keiichi Koizumi, Minako Hoshiai, Hideaki Yagasaki, Takako Toda, Atsushi Watanabe, Hiroaki Kise, Takaya Nakane, Youhei Hasebe, Kanji Sugita
Publikováno v:
American Journal of Medical Genetics Part A. 167:3144-3147
Most cases of Noonan syndrome (NS) result from mutations in one of the RAS-MAPK signaling genes, including PTPN11, SOS1, KRAS, NRAS, RAF1, BRAF, SHOC2, MEK1 (MAP2K1), and CBL. Cardiovascular diseases of varying severity, such as pulmonary stenosis an
Autor:
Keiichi Koizumi, Takako Toda, Hiroaki Kise, Takeshi Moriguchi, Nobuyuki Katsumata, Youhei Hasebe, Minako Hoshiai, Kenichi Matsuda, Kanji Sugita
Publikováno v:
Pediatric Cardiology and Cardiac Surgery. 31:246-253
Autor:
Kentaro Kamiya, Masahiko Matsumoto, Keiichi Koizumi, Yukiyo Yoshida, Hiroaki Kise, Kenji Sakakibara, Youhei Hasebe, Shigeaki Kaga, Shoji Suzuki, Shinya Motohashi, Minako Hoshiai, Kanji Sugita
Publikováno v:
Pediatric Cardiology and Cardiac Surgery. 28:218-223
Autor:
Nobuyuki Katsumata, Yoshimi Kaga, Keiichi Koizumi, Takako Toda, Hiroaki Kise, Youhei Hasebe, Kanji Sugita, Minako Hoshiai
Publikováno v:
Circulation. 131
Background: Infliximab (IFX) which is an anti-TNFα monoclonal antibody is effective in the treatment of gamma globulin treatment (IVIG) resistance Kawasaki disease (KD) . It has been reported that TNFα adjusts the gene expression of myelin protein